Cargando…

Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol

INTRODUCTION: The COVID-19 pandemic was preceded by an ongoing overdose crisis and linked to escalating drug overdose deaths in British Columbia (BC). At the outset of these dual public health emergencies, the BC government announced interim Risk Mitigation Guidance (RMG) that permitted prescribing...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosyk, Bohdan, Slaunwhite, Amanda, Urbanoski, Karen, Hongdilokkul, Natt, Palis, Heather, Lock, Kurt, Min, Jeong E, Zhao, Bin, Card, Kiffer G, Barker, Brittany, Meilleur, Louise, Burmeister, Charlene, Thomson, Erica, Beck-McGreevy, Phoenix, Pauly, Bernie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190984/
https://www.ncbi.nlm.nih.gov/pubmed/34108170
http://dx.doi.org/10.1136/bmjopen-2020-048353
_version_ 1783705787140407296
author Nosyk, Bohdan
Slaunwhite, Amanda
Urbanoski, Karen
Hongdilokkul, Natt
Palis, Heather
Lock, Kurt
Min, Jeong E
Zhao, Bin
Card, Kiffer G
Barker, Brittany
Meilleur, Louise
Burmeister, Charlene
Thomson, Erica
Beck-McGreevy, Phoenix
Pauly, Bernie
author_facet Nosyk, Bohdan
Slaunwhite, Amanda
Urbanoski, Karen
Hongdilokkul, Natt
Palis, Heather
Lock, Kurt
Min, Jeong E
Zhao, Bin
Card, Kiffer G
Barker, Brittany
Meilleur, Louise
Burmeister, Charlene
Thomson, Erica
Beck-McGreevy, Phoenix
Pauly, Bernie
author_sort Nosyk, Bohdan
collection PubMed
description INTRODUCTION: The COVID-19 pandemic was preceded by an ongoing overdose crisis and linked to escalating drug overdose deaths in British Columbia (BC). At the outset of these dual public health emergencies, the BC government announced interim Risk Mitigation Guidance (RMG) that permitted prescribing medication alternatives to substances, including opioids, alcohol, stimulants and benzodiazepines, an intervention sometimes referred to as ‘safe supply’. This protocol outlines the approach for a study of the implementation of RMG and its impacts on COVID-19 infection, drug-related and systemic harms, continuity of care for people with substance use disorder (SUD), as well as their behavioural, psychosocial and well-being outcomes. METHODS AND ANALYSIS: We conducted a parallel mixed-method study that involved both analysis of population-level administrative health data and primary data collection, including a 10-week longitudinal observational study (target n=200), a cross-sectional survey (target n=200) and qualitative interviews (target n=60). We implemented a participatory approach to this evaluation, partnering with people with lived or living expertise of drug use, and researchers and public health decision-makers across the province. Linked population-level administrative databases will analyse data from a cohort of BC residents with an indication of SUD between 1996 and 2020. We will execute high-dimensional propensity score matching and marginal structural modelling to construct a control group and to assess the impact of RMG dispensation receipt on a collaboratively determined set of primary and secondary outcomes. ETHICS AND DISSEMINATION: Study activities were developed to adhere to the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, recommended COVID-19 research practices, and guided by the Truth and Reconciliation Commission’s Calls to Action for public health, data governance and research ethics related to Indigenous people. Results will be disseminated incrementally, on an ongoing basis, through the consortium established for this study, then published in peer-reviewed journals.
format Online
Article
Text
id pubmed-8190984
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81909842021-06-11 Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol Nosyk, Bohdan Slaunwhite, Amanda Urbanoski, Karen Hongdilokkul, Natt Palis, Heather Lock, Kurt Min, Jeong E Zhao, Bin Card, Kiffer G Barker, Brittany Meilleur, Louise Burmeister, Charlene Thomson, Erica Beck-McGreevy, Phoenix Pauly, Bernie BMJ Open Addiction INTRODUCTION: The COVID-19 pandemic was preceded by an ongoing overdose crisis and linked to escalating drug overdose deaths in British Columbia (BC). At the outset of these dual public health emergencies, the BC government announced interim Risk Mitigation Guidance (RMG) that permitted prescribing medication alternatives to substances, including opioids, alcohol, stimulants and benzodiazepines, an intervention sometimes referred to as ‘safe supply’. This protocol outlines the approach for a study of the implementation of RMG and its impacts on COVID-19 infection, drug-related and systemic harms, continuity of care for people with substance use disorder (SUD), as well as their behavioural, psychosocial and well-being outcomes. METHODS AND ANALYSIS: We conducted a parallel mixed-method study that involved both analysis of population-level administrative health data and primary data collection, including a 10-week longitudinal observational study (target n=200), a cross-sectional survey (target n=200) and qualitative interviews (target n=60). We implemented a participatory approach to this evaluation, partnering with people with lived or living expertise of drug use, and researchers and public health decision-makers across the province. Linked population-level administrative databases will analyse data from a cohort of BC residents with an indication of SUD between 1996 and 2020. We will execute high-dimensional propensity score matching and marginal structural modelling to construct a control group and to assess the impact of RMG dispensation receipt on a collaboratively determined set of primary and secondary outcomes. ETHICS AND DISSEMINATION: Study activities were developed to adhere to the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, recommended COVID-19 research practices, and guided by the Truth and Reconciliation Commission’s Calls to Action for public health, data governance and research ethics related to Indigenous people. Results will be disseminated incrementally, on an ongoing basis, through the consortium established for this study, then published in peer-reviewed journals. BMJ Publishing Group 2021-06-09 /pmc/articles/PMC8190984/ /pubmed/34108170 http://dx.doi.org/10.1136/bmjopen-2020-048353 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Addiction
Nosyk, Bohdan
Slaunwhite, Amanda
Urbanoski, Karen
Hongdilokkul, Natt
Palis, Heather
Lock, Kurt
Min, Jeong E
Zhao, Bin
Card, Kiffer G
Barker, Brittany
Meilleur, Louise
Burmeister, Charlene
Thomson, Erica
Beck-McGreevy, Phoenix
Pauly, Bernie
Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
title Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
title_full Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
title_fullStr Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
title_full_unstemmed Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
title_short Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
title_sort evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of covid-19 and overdose in british columbia: a mixed-method study protocol
topic Addiction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190984/
https://www.ncbi.nlm.nih.gov/pubmed/34108170
http://dx.doi.org/10.1136/bmjopen-2020-048353
work_keys_str_mv AT nosykbohdan evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT slaunwhiteamanda evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT urbanoskikaren evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT hongdilokkulnatt evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT palisheather evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT lockkurt evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT minjeonge evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT zhaobin evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT cardkifferg evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT barkerbrittany evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT meilleurlouise evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT burmeistercharlene evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT thomsonerica evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT beckmcgreevyphoenix evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol
AT paulybernie evaluationofriskmitigationmeasuresforpeoplewithsubstanceusedisorderstoaddressthedualpublichealthcrisesofcovid19andoverdoseinbritishcolumbiaamixedmethodstudyprotocol